Insider · CIK 0001352908

Hayden Michael R

Reports to the SEC for 5 companies · VANCOUVER

sec.gov

Transactions

Companies

Filings

CIK

0001352908

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-24	ABCLAbCellera Biologics Inc.P Purchase	Director	PPurchase	+53.6K sh	$10.64	+$570K	1,373,397
2026-08-12	ABCLAbCellera Biologics Inc.P Purchase	Director	PPurchase	+46.4K sh	$10.37	+$481K	1,319,784
2026-08-11	ABCLAbCellera Biologics Inc.G Gift	Director	GGift	−50K sh	—	—	1,273,397
2026-07-31	IONSIONIS PHARMACEUTICALS INCP Purchase	Director	PPurchase	+5,000 sh	$51.60	+$258K	24,000
2026-07-30	IONSIONIS PHARMACEUTICALS INCP Purchase	Director	PPurchase	+15K sh	$53.38	+$801K	19,000
2026-07-01	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,369 sh	—	—	5,369
2026-07-01	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	Director	AAward	+2,301 sh	—	—	12,198
2026-06-11	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Director	AAward	+112K sh	—	—	1,011,544
2025-10-30	ETNB89bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−61.5K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,933 sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45.2K sh	—	—	0
2025-10-30	ETNB89bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−80.9K sh	—	—	0
2025-10-30	ETNB89bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−104K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.6K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−56.4K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.4K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.7K sh	—	—	0
2025-07-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,079 sh	—	—	9,897
2025-07-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+4,079 sh	—	—	54,298
2025-07-01	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,518
2025-07-01	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	Director	AAward	+5,220 sh	—	—	13,976
2025-06-12	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Director	AAward	+239K sh	—	—	899,843
2025-05-01	IONSIONIS PHARMACEUTICALS INCP Purchase	Director	PPurchase	+15K sh	$31.86	+$478K	50,219
2025-02-03	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+56.4K sh	—	—	56,400
2024-12-23	IONSIONIS PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,500 sh	$36.23	+$90.6K	35,219
2024-12-23	IONSIONIS PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,500 sh	$36.20	+$90.5K	32,719
2024-07-01	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10.1K sh	—	—	10,111
2024-07-01	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	Director	AAward	+4,079 sh	—	—	8,756
2024-06-21	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Director	AAward	+164K sh	—	—	660,979
2024-02-01	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45.2K sh	—	—	45,150
2023-09-22	ABCLAbCellera Biologics Inc.P Purchase	Director	PPurchase	+20K sh	$4.91	+$98.2K	1,323,397
2023-08-08	ABCLAbCellera Biologics Inc.P Purchase	Director	PPurchase	+30K sh	$5.90	+$177K	1,303,397
2023-07-17	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,777 sh	—	—	24,886
2023-07-17	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−5,333 sh	—	—	4,677
2023-07-17	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,777 sh	—	—	10,010
2023-07-17	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,333 sh	—	—	30,219
2023-07-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10.3K sh	—	—	10,321
2023-07-03	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	Director	AAward	+4,677 sh	—	—	11,787
2023-03-28	ETNB89bio, Inc.P Purchase	Director	PPurchase	+61.5K sh	$16.15	+$994K	61,538
2023-02-09	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.4K sh	—	—	27,400
2022-12-01	ABCLAbCellera Biologics Inc. · Share Option (right to buy)A Award	Director	AAward	+47.2K sh	—	—	497,045
2022-10-17	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,777 sh	—	—	7,110
2022-10-17	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,777 sh	—	—	23,109
2022-07-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,777 sh	—	—	8,887
2022-07-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−5,333 sh	—	—	10,664
2022-07-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,777 sh	—	—	21,332

Recent filings

Accepted (ET)
Aug 244
Hayden Michael R0001628280-26-058684
SEC(opens sec.gov)
Aug 144
Hayden Michael R0001628280-26-057007
SEC(opens sec.gov)
Aug 134
Hayden Michael R0001628280-26-056653
SEC(opens sec.gov)
Jul 314
Hayden Michael R0000874015-26-000254
SEC(opens sec.gov)
Jul 64
Hayden Michael R0000874015-26-000228
SEC(opens sec.gov)
Jun 124
Hayden Michael R0001628280-26-042739
SEC(opens sec.gov)
Oct 304
Hayden Michael R0001193125-25-259064
SEC(opens sec.gov)

Companies

Address

C/O ABCELLERA BIOLOGICS INC 150 W 4TH AVENUE

VANCOUVER